Dr. Amr Moursi · Neuromodulation vs. Neuroablation | Functional Neurosurgery Explained – Episode 3
Follow
Video·Published Mar 2026

Neuromodulation vs. Neuroablation | Functional Neurosurgery Explained – Episode 3

With Dr. Amr Moursi

Chapter 1 of 1 · Fundamentals

Introduction

Series introduction and episode overview

Try
Intelligent Search· scoped to Parkinson's disease · not medical adviceSearch the whole library →
What the experts said0 expert statements · 6 host summaries
Parkinson's disease is a circuit disorder, not just a dopamine deficiency.
Host summaryThe host summarizing a resource · not cited in answers
The subthalamic nucleus becomes overactive in Parkinson's disease despite being structurally intact.
Host summaryThe host summarizing a resource · not cited in answers
Irreversibility was the fatal limitation of thalamotomy and pallidotomy.
Host summaryThe host summarizing a resource · not cited in answers
Benabid discovered in Grenoble in 1987 that high-frequency stimulation could replicate the effects of ablative lesions reversibly, shifting the entire question of surgery.
Host summaryThe host summarizing a resource · not cited in answers
Adaptive closed-loop DBS represents the future of the field.
Host summaryThe host summarizing a resource · not cited in answers
The first thalamotomies for Parkinson's disease were performed in the 1950s.
Host summaryThe host summarizing a resource · not cited in answers